Zemplar (AbbVie Inc.)
Welcome to the PulseAid listing for the Zemplar drug offered from AbbVie Inc.. This Cholecalciferol [Chemical/Ingredient],Vitamin D3 Analog [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | AbbVie Inc. |
| NON-PROPRIETARY NAME: | Paricalcitol |
| SUBSTANCE NAME: | PARICALCITOL |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Cholecalciferol [Chemical/Ingredient],Vitamin D3 Analog [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1998-04-17 |
| END MARKETING DATE: | 0000-00-00 |
Zemplar HUMAN PRESCRIPTION DRUG Details:
| Item Description | Zemplar from AbbVie Inc. |
| LABELER NAME: | AbbVie Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 5(ug/mL) |
| START MARKETING DATE: | 1998-04-17 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0074-1658_093873ff-4f54-1aeb-bb3f-0c27d18c3e18 |
| PRODUCT NDC: | 0074-1658 |
| APPLICATION NUMBER: | NDA020819 |
Other PARICALCITOL Pharmaceutical Manufacturers / Labelers:
